TB

Tjeerd Barf

AB Acerta Pharma B.V.: 3 patents #1 of 14Top 8%
Merck: 1 patents #377 of 961Top 40%
📍 Ravenstein, NL: #1 of 2 inventorsTop 50%
Overall (2019): #42,129 of 560,194Top 8%
4
Patents 2019

Issued Patents 2019

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
10328080 Therapeutic combination of PI3K inhibitor and a BTK inhibitor Ahmed Hamdy, Wayne Rothbaum, Raquel Izumi, Brian Lannutti, Todd Covey +3 more 2019-06-25
10272083 Methods of treating chronic lymphocytic leukemia and small lymphocytic leukemia using a BTK inhibitor Ahmed Hamdy, Wayne Rothbaum, Raquel Izumi, Brian Lannutti, Todd Covey +3 more 2019-04-30
10239883 4-imidazopyridazin-1-yl-benzamides as BTK inhibitors Christiaan Gerardus Johannes Maria Jans, Adrianus Petrus Antonius De Man, Arthur A. Oubrie, Hans C. A. Raaijmakers, Johannes Bernardus Maria Rewinkel +2 more 2019-03-26
10167291 Pharmaceutical composition comprising a crystal form of (S)-4-(8-amino-3-(1-(but-2-ynoyl) pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide Fritz Blatter, Tim Ingallinera, Edwin Aret, Cecile M. Krejsa, Jerry Evarts 2019-01-01